GoodRx Holdings

General Information
Business:

 

Our mission is to help Americans get the healthcare they need at a price they can afford. To achieve this, we are building the leading, consumer-focused digital healthcare platform in the United States.

GoodRx was founded to solve the challenges that consumers face in understanding, accessing, and affording healthcare. We started with a price comparison tool for prescriptions, offering consumers free access to lower prices on their medication. We wanted to help ensure that no parent had to choose between their child’s next meal and their life-saving medication. Today, we believe our expanded platform improves the health and financial well-being of American families by providing easy access to price transparency and affordability solutions for generic and brand medications, affordable and convenient medical provider consultations via telehealth and additional healthcare services and information. Based on our research, from inception through June 30, 2020, we estimate that approximately 18 million of our consumers could not have afforded to fill their prescriptions without the savings provided by GoodRx. Furthermore, a July 2020 survey we commissioned from Lab42 Research LLC found that 68% of healthcare providers surveyed have recommended GoodRx to patients. In addition to reducing the costs of healthcare for consumers, we believe that our offerings can help drive greater medication adherence, faster treatment and better patient outcomes. These all contribute to a healthier, happier society.

Industry: COMPUTER PROCESSING & DATA PREPARATION
Employees: 388
Founded: 2011
Contact Information
Address 233 Wilshire Blvd., Suite 990, Santa Monica, CA 90401, US
Phone Number (855) 268-2822
Web Address http://www.goodrx.com
View Prospectus: GoodRx Holdings
Financial Information
Market Cap $1269.18mil
Revenues $627.7 mil (last 12 months)
Net Income $89.5 mil (last 12 months)
IPO Profile
Symbol GDRX
Exchange NASDAQ
Shares (millions): 34.6
Price range $33.00 - $33.00
Est. $ Volume $1141.8 mil
Manager / Joint Managers Morgan Stanley/ Goldman Sachs/ J.P. Morgan/ Barclays
CO-Managers BofA Securities/ Citigroup/ Credit Suisse/ RBC Capital Markets/ UBS Investment Bank/ Cowen/ Deutsche Bank Securities/ Evercore ISI/ Citizens Capital Markets/ KKR/ LionTree/ Raymond James/ SVB Leerink/ Academy Securities/ Loop Capital Markets/ R. Seelaus/ Ramirez
Expected To Trade: 9/23/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change